Suppr超能文献

肝门淋巴结作为原发性胆汁性肝硬化的随访因素:一项超声研究

Hepatic lymph nodes as follow-up factor in primary biliary cirrhosis. An ultrasound study.

作者信息

Lyttkens K, Prytz H, Forsberg L, Hägerstrand I

机构信息

Dept. of Diagnostic Radiology, University Hospital, Lund, Sweden.

出版信息

Scand J Gastroenterol. 1995 Oct;30(10):1036-40. doi: 10.3109/00365529509096350.

Abstract

BACKGROUND

The aim of this study was to investigate whether changes in lymph node size in the hepatoduodenal ligament reflect changes in biochemical and histologic markers of cholestasis, hepatocellular damage, and humoral immunoreactivity in patients with primary biliary cirrhosis (PBC).

METHODS

Twenty-three consecutive patients were examined with repeated liver biopsies, laboratory tests, and ultrasonographic examinations of the hepatoduodenal ligament. The effect of treatment with ursodeoxycholic acid (UDCA) on these factors was also studied.

RESULTS

A correlation was found between changes in lymph node size and changes in markers of hepatocellular damage, cholestasis, and humoral immunoreactivity and also with intralobular inflammation. In the UDCA-treated patients the node size decreased slightly during 2 years of treatment, whereas it was unchanged in the control group (p = 0.0528).

CONCLUSIONS

Changes in the size of the lymph nodes in the hepatoduodenal ligament may reflect inflammation and cholestasis in PBC and thus be a valuable indicator in the follow-up of patients with this disease.

摘要

背景

本研究旨在调查肝十二指肠韧带淋巴结大小的变化是否反映原发性胆汁性肝硬化(PBC)患者胆汁淤积、肝细胞损伤及体液免疫反应的生化和组织学标志物的变化。

方法

对23例连续患者进行重复肝脏活检、实验室检查及肝十二指肠韧带超声检查。还研究了熊去氧胆酸(UDCA)治疗对这些因素的影响。

结果

发现淋巴结大小变化与肝细胞损伤、胆汁淤积、体液免疫反应标志物变化以及小叶内炎症之间存在相关性。在接受UDCA治疗的患者中,治疗2年期间淋巴结大小略有减小,而对照组则无变化(p = 0.0528)。

结论

肝十二指肠韧带淋巴结大小的变化可能反映PBC中的炎症和胆汁淤积,因此是该疾病患者随访中的一个有价值指标。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验